About CCBR Aalborg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
4
Nordic Bioscience A/S
3
Pfizer
3
Biogen
2
AstraZeneca
1
C4Pain
1
Coloplast A/S
1
Eli Lilly and Company
1
Menarini Group
1
Purdue Pharma LP
1
Statens Serum Institut
1
Clinical Trials at CCBR Aalborg
During the past decade, CCBR Aalborg conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
2005-09-01
2006-05-01
Completed
962
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
355
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2005-12-01
2007-06-01
Completed
418
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2006-08-01
2008-04-01
Completed
214
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis
2007-05-01
2010-09-01
Completed
1,176
A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
2007-03-01
2011-11-01
Completed
4,665
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)
2008-06-01
2011-06-01
Terminated
1,030
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCBR Aalborg" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Nordic Bioscience A/S" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Biogen" with 2 trials sponsored and "AstraZeneca"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR Aalborg"
#1 collaborator was "Novartis" with 3 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "CCBR Clinical Research" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at CCBR Aalborg
According to Clinical.Site data, the most researched conditions in "CCBR Aalborg" are
"Osteoarthritis" (4 trials), "Alzheimer's Disease" (3 trials), "Dyslipidemia" (3 trials), "Cardiovascular Disease" (2 trials) and "Type II Diabetes Mellitus" (2 trials). Many other conditions were trialed in "CCBR Aalborg" in a lesser frequency.
Clinical Trials Intervention Types at CCBR Aalborg
Most popular intervention types in "CCBR Aalborg" are "Drug" (18 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Pitavastatin" (3 trials), "Atorvastatin" (2 trials), "SMC021 Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CCBR Aalborg
The vast majority of trials in "CCBR Aalborg" are
17 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at CCBR Aalborg
Currently, there are NaN active trials in "CCBR Aalborg".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in CCBR Aalborg,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in CCBR Aalborg, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".